Pages that link to "Q69348869"
Jump to navigation
Jump to search
The following pages link to BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons (Q69348869):
Displaying 32 items.
- Expression of serotonin receptor mRNAs in blood vessels (Q28296354) (← links)
- 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum (Q28298264) (← links)
- The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants (Q28368220) (← links)
- 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice (Q30490465) (← links)
- Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats (Q33322577) (← links)
- Serotonin: a mediator of the brain-gut connection (Q34070408) (← links)
- Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in braina (Q34498523) (← links)
- Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants. (Q34666955) (← links)
- A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat (Q35851456) (← links)
- 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis (Q36711373) (← links)
- Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology (Q36726602) (← links)
- Presynaptic control of serotonin on striatal dopamine function (Q37800812) (← links)
- Identification of patients with non-d, non-C irritable bowel syndrome and treatment with renzapride: an exploratory, multicenter, randomized, double-blind, placebo-controlled clinical trial. (Q39320091) (← links)
- 5-hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors (Q41084675) (← links)
- 5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells (Q41396845) (← links)
- Characterization of a serotonin receptor endogenous to frog melanophores (Q41499549) (← links)
- Dual effects of 5-hydroxytryptamine on the release of gamma-aminobutyric acid from myenteric neurones of the guinea-pig ileum (Q42111881) (← links)
- 5-Hydroxytryptamine receptors with a 5-HT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes (Q42488807) (← links)
- Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro (Q42562526) (← links)
- Zacopride and BRL 24924 induce an increase in EEG-energy in rats (Q42562741) (← links)
- 5-hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction (Q42822232) (← links)
- The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons (Q46224812) (← links)
- Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285 (Q48523967) (← links)
- A 5-HT4-like receptor in human right atrium. (Q53858263) (← links)
- Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs (Q60701664) (← links)
- 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae (Q67959203) (← links)
- 5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle (Q67971691) (← links)
- Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype (Q68626680) (← links)
- Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990 (Q68840289) (← links)
- Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents (Q77904056) (← links)
- Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome (Q83333177) (← links)
- Prophylactic efficacy of 5-HT4R agonists against stress (Q90631883) (← links)